Back to Search
ANTHONY ZACHAREK, MD
MD
Plastic and Reconstructive Surgery Physician
NPI: 1528063724IndividualAccepts Medicare
Specialties, Licenses & Credentials
Plastic and Reconstructive Surgery PhysicianPrimary
Surgery — Plastic and Reconstructive Surgery
Code: 2086S0122X
4301092792(MI)
CMS Specialties
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke.
PMID 18927449·Stroke·2009
7-preclinical
Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
PMID 17356562·J Cereb Blood Flow Metab·2007
7-preclinical
Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder rats.
PMID 16730914·Neuroscience·2006
4-observational
Bone marrow stromal cells upregulate expression of bone morphogenetic proteins 2 and 4, gap junction protein connexin-43 and synaptophysin after stroke in rats.
PMID 16730912·Neuroscience·2006
4-observational
Nitric oxide regulates Angiopoietin1/Tie2 expression after stroke.
PMID 16762501·Neurosci Lett·2006
7-preclinical
Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway.
PMID 19109527·Am J Physiol Cell Physiol·2009
7-preclinical
Nitric oxide donor up-regulation of SDF1/CXCR4 and Ang1/Tie2 promotes neuroblast cell migration after stroke.
PMID 18711749·J Neurosci Res·2009
7-preclinical
eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice.
PMID 19443804·Stroke·2009
7-preclinical
Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke.
PMID 19591934·Neurobiol Dis·2009
7-preclinical
Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke.
PMID 18544044·J Cell Mol Med·2009
7-preclinical
Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke.
PMID 19223914·J Cereb Blood Flow Metab·2009
7-preclinical
Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice.
PMID 19154781·Neuroscience·2009
7-preclinical
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
PMID 18172303·Cancer Res·2008
8-other
Treatment of stroke with (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl) amino] diazen-1-ium-1, 2-diolate and bone marrow stromal cells upregulates angiopoietin-1/Tie2 and enhances neovascularization.
PMID 18691637·Neuroscience·2008
7-preclinical
Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke.
PMID 18063826·Stroke·2008
7-preclinical
Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.
PMID 17641243·Stem Cells·2007
4-observational
Niaspan increases angiogenesis and improves functional recovery after stroke.
PMID 17557352·Ann Neurol·2007
7-preclinical
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke.
PMID 16596121·J Cereb Blood Flow Metab·2007
7-preclinical
Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells.
PMID 16638750·J Biol Chem·2006
8-other
N-cadherin mediates nitric oxide-induced neurogenesis in young and retired breeder neurospheres.
PMID 16580782·Neuroscience·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 COOPER AVE STE 1
SAGINAW, MI 48602 - Phone
- (989) 753-2061
Quick Facts
- NPI
- 1528063724
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile